Cambridge Catalog  
  • Your account
  • View basket
  • Help
Home > Catalog > Antipsychotics and Mood Stabilizers
Antipsychotics and Mood Stabilizers
AddThis

Details

  • 190 colour illus. 16 tables
  • Page extent: 248 pages
  • Size: 253 x 177 mm
  • Weight: 0.49 kg
Add to basket

Paperback

 (ISBN-13: 9780521714136)

  • Also available in Hardback
  • Published March 2008

In stock

$52.00 (M)

Relying upon the best-selling third edition of Stahl’s Essential Psychopharmacology, Dr. Stephen M. Stahl has revised chapters covering antipsychotics and mood stabilizers for this third edition of Antipsychotics and Mood Stabilizers. More than one-third longer than the previous edition, Antipsychotics and Mood Stabilizers is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. This updated edition includes advances in neurobiology and recent clinical developments to explain the concepts underlying drug treatment of psychiatric disorders. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics not covered in the previous edition. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike.

Contents

1. Psychosis and schizophrenia; 2. Antipsychotic agents.

Review

"Stephen Stahl is one of the most recognizable names in psychopharmacology. He is an inspiring teacher who has a knack for synthesizing complex scientific information for students, residents, psychiatrists, and nonmedical mental health practitioners....[H]e has started publishing psychopharmacology books that are not only very readable and up-to-date, but are in my opinion the most creatively illustrated texts of psychopharmacology. My trainees rave about his books and quote them often."
--Journal of Clinical Psychiatry

 

Accreditation and Credit Designation Statements
The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Sponsorship Information
Sponsored by Neuroscience Education Institute

Support
This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.

printer iconPrinter friendly versionemail iconEmail a colleague AddThis